Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| TR1-H5254 | Human | Human TRAIL R1 / DR4 / TNFRSF10A Protein, Fc Tag |  |
|
|
| TR1-H5228 | Human | Human TRAIL R1 / DR4 / TNFRSF10A Protein, His Tag |  |
|
|
Loaded Human TRAIL R1, Fc Tag (Cat. No. TR1-H5254) on AHC Biosensor, can bind Human TRAIL, His Tag with an affinity constant of 0.891 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Aponermin | Approved | Beijing Shadong Biotech Co Ltd | 沙艾特 | Mainland China | Multiple Myeloma | Wuhan Hiteck Biological Pharma Co Ltd | 2023-11-02 | Multiple Myeloma | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Dulanermin (Shanghai GeBaiDe) | Phase 3 Clinical | Shanghai Gebaide Biotechnology Co Ltd | Carcinoma, Non-Small-Cell Lung | Details | |
| Recombinant human tumor necrosis factor-related apoptosis-inducing ligand (Shenzhen Xinpeng Biotech) | Phase 3 Clinical | Shenzhen Sinobioway Xinpeng Biomedicine Co Ltd | Neoplasms | Details | |
| Rilunermin alfa | SCB-313 (TRAIL-Trimer) | Phase 1 Clinical | Hydrothorax; Ascites; Peritoneal Neoplasms; Pleural Effusion, Malignant | Details | |
| HLX56 | HLX56; HLX-56 | Phase 1 Clinical | Shanghai Henlius Biotech Inc | Solid tumours | Details |
This web search service is supported by Google Inc.
A-Z
